Professor of Psychiatry
- Phone: 314-286-1700
- Email: firstname.lastname@example.org
Additional Titles & Roles
- Director, Treatment Resistant Depression and Neurostimulation Clinic
- Director, Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders (CARRMA)
- Interventional Psychiatry Rotation Director
Education & Training
- Residency: Duke University, Durham, NC, 1999
- MD: University of Missouri, Columbia, MO, 1995
- BA: Biology: St. Louis University, St. Louis, MO, 1987
- Ziskind-Somerfeld Research Award, Society of Biological Psychiatry, 2016
- Best Doctors in America, (Best Doctors, Inc.), 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019
- Resident Faculty Teaching Award, Washington University, 2014
- Resident Mentor Award, Washington University, 2011
- NARSAD Sidney Baer Award, 2007
- Resident Faculty Teaching Award, St. Louis University, 2004, 2007
Areas of Clinical Interest
mood disorders, treatment-resistant mood disorders, bipolar disorders
treatment-resistant depression (TRD) phenomenology, novel treatments for TRD, neuroimaging of mood disorders, bipolar disorders
- Conway CR, Kumar A, Xiong W, Bunker M, Aaronson ST, Rush AJ. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. J Clin Psychiatry. 2018; Aug 21;79(5). PMID: 30152645.
Read publication »Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
- Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality. Am J Psychiatry, 2017 Mar. PMID: 28359201.
Read publication »A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
- Conway CR, George MS, Sackeim HA. Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry, 2017. 74(1): 9-10. PMID: 27784055.
Read publication »Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough.
- Conway CR, Gebara MA, Walker MC, Lessov-Schlaggar CN, Janski AM, Chibnall JT, Cristancho P, Sheline YS, Gott BM, Svrakic DM. Clinical Characteristics and Management of Treatment-Resistant Depression. J Clin Psych, 2015; Nov; 76(11): 1569-70. PMID: 26646033.
- Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP, Zorumski CF, Conway CR. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Biological Psychiatry. 2015; Jul 1; 78(1). PMID: 25577164.
- Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI. Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimulation, 2013; 6(5): 788-97. PMCID: PMC3954813.
Funded Research Projects
American Foundation of Suicide Prevention (Co-PI). Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients.
Assurex Health (PI). Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder (MDD).
Brain and Behavior Research Foundation (Co-I). Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies.
NIMH R21 (Co-PI). Targeting Affective Circuits Using the N-methyl-D-Aspartate (NMDA) Antagonist Nitrous Oxide.
Taylor Family Institute for Innovative Psychiatric Research (PI): Biological and Psychological Phenomenology Studies of Treatment-Resistant Depressive Disorder.